. Author manuscript; available in PMC: 2023 Jun 1.

Published in final edited form as: Br J Ophthalmol. 2021 Oct 20:bjophthalmol-2021-319427. doi: 10.1136/bjophthalmol-2021-319427

Table 1.

Axial Length Changes After Sub-Tenon Injection of Crosslinking Agent

	Right Eye (Treated) Mean +/− SD (n)	Right Eye (Sham) Mean +/− SD (n)	P-value
Baseline Axial Length on Day 0 (in mm)	13.78 +/− 0.1 (n=5)	13.7 +/− 0.1 (n=5)	0.60
Change in Axial length (mm)
At Day 13 (n=5)	0.34 +/− 0.14	0.40 +/− 0.10	0.42
At Day 19 (n=3)	0.65 +/− 0.12	0.73 +/− 0.23	0.64
At Day 27 (n=4)	0.80 +/− 0.12	0.94 +/− 0.13	0.15
At Day 35 (n=3)	1.05 +/− 0.05	1.19 +/− 0.05	0.02*

Bold font and asterisk denote statistical significance at p < 0.05. Baseline axial length was measured on Day 0 (defined as the first day of treatment). mm = millimeters. n = sample size. SD = standard deviation.